Mayer B. Davidson, M.D. is Professor of Medicine at the University of California, Los Angeles School of Medicine and Director of the Clinical Trials Unit at Charles R. Drew University of Medicine and Science. Dr. Davidson was President of the American Diabetes Association for 1997-1998. A renowned researcher and speaker on type 2 diabetes and insulin resistance, Dr. Davidson has presented hundreds of lectures nationally. He has served on the Editorial Boards of Diabetes Care, Diabetes Spectrum, Clinical Diabetes, Geriatrics and the Journal of Clinical Endocrinology and Metabolism and was a Consulting Editor of Hippocrates. He currently serves on the Editorial Boards of Diabetes Research & Clinical Practice. He is an Associate Editor of Endo Trends and was the Founding Editor of Current Diabetes Reports. Currently, he is the Editor-in-Chief of Diabetes Care. Dr. Davidson’s contributions to the medical literature include 148 scientific papers, 29 book chapters, and 89 reviews, editorials, and invited articles. He is the main author of the textbook, Diabetes Mellitus: Diagnosis and Treatment, the 4th edition of which was published in 1998 and has been translated into Italian and Portuguese. The fifth edition, Davidson’s Diabetes Mellitus: Diagnosis and Treatment, was updated by two of his colleagues and published in 2004. Finally, he wrote (along with a professional writer) The Complete Idiot’s Guide to Type 2 Diabetes.

Daniel Einhorn, M.D. is a Clinical Professor of Medicine at University of California, San Diego and the Medical Director of the Scripps Whittier Institute for Diabetes and in clinical practice in La Jolla, California. He received his B.A. from Yale University (Summa Cum Laude, Phi Beta Kappa, Varsity Letter) and his M.D. from Tufts Medical School (Alpha Omega Alpha). He did his internship, residency and Fellowship, and then served as an Instructor in Medicine at Beth Israel Hospital, Harvard Medical School. Since 1984 he has been a clinical endocrinologist with Diabetes and Endocrine Associates, Associate Clinical Professor of Medicine at UC San Diego, Director of the Diabetes Treatment and Research Center at Sharp HealthCare, and Director of Clinical Research for the Scripps Whittier Institute of Diabetes. He is a Fellow of the American College of Physicians and the American College of Endocrinology. Dr. Einhorn was Co-Chairman of the American College of Endocrinology Task Force and the Consensus Conference on The Insulin Resistance Syndrome. He is also past Chairman of Clinical Research, past Chairman of Membership, and was six years on the Board of Directors, American Association of Clinical Endocrinologists (AACE). He is on the Board and the Executive Committee of the California Chapter of AACE and participated in regional AACE programs. He has presented at national AACE meetings for the past 10 years on subjects ranging from the evolving role of the clinical endocrinologist to clinical strategies, devices, and novel compounds. He has served on many AACE Committees including Strategic Planning, Nominating, and International Membership. He was the endocrinologist representative on the American Medical Association’s Diabetes Advisory Council. He served on The Endocrine Society’s (ES) Clinical Affairs Committee, the American Diabetes Association (ADA) Managed Care Initiative and on the regional ADA and Juvenile Diabetes Foundation Boards of Directors. He is past Chairman of the Diabetes and Pregnancy Program of San Diego and Imperial Counties. Dr. Einhorn is Co-Editor of Endocrinology and Metabolism Clinics of North America: Type 2 Diabetes and Cardiovascular Disease, and he writes a monthly column on diabetes for the popular magazine Diabetes Health. His research and publications cover diabetes prevention and reversal, recognition and treatment of diabetic complications, new technologies and pharmaceuticals, combination therapies, and clinical decision-making. He has lectured nationally and internationally on these topics, and has chaired meetings of the American Federation of Clinical Research in Carmel, The Endocrine Society Clinical Endocrine Update (The Postgraduate Meetings) in Diabetes, symposia of AACE, and over 250 regional symposia. Dr. Einhorn consults to biotech and investment companies as well as to pharmaceutical companies in the design and interpretation of clinical studies. He reviews articles for Diabetes Care, The American Journal of Medicine, The Journal of the American Medical Association and The Journal of Endocrinology and Metabolism, and he serves on the Editorial Board of Diabetes Health.

Gerald M. Reaven, M.D. is Professor of Medicine (Active Emeritus) in the Division of Cardiovascular Medicine, Stanford University School of Medicine. During his 40+ years on the faculty at Stanford, Dr. Reaven has served as the Head of the Division of Endocrinology and Metabolic Diseases (1974-1977), Head of the Division of Gerontology (1977-1990) and Head of the Division of Endocrinology, Gerontology, and Metabolism (1990-1995). He initiated the program in aging at Stanford, and served as Director of the Geriatric Research, Education, and Clinical Center at the Veterans Affairs Palo Alto Health Care System (1977-1995). In addition, Dr. Reaven played a key role in establishing the General Clinical Research Center of Stanford, and served as its Director (1977-1990). An internationally recognized expert in diabetes and other metabolic disorders, Dr. Reaven has published over 500 peer-reviewed research articles in scientific journals, and has authored numerous textbook chapters and other scholarly works. The quality of his research has been widely recognized, and he has received the highest awards for scientific achievement from the American Diabetes Association (Banting Award for Distinguished Scientific Achievement, 1988), the British Diabetes Association (Banting Memorial Lecture, 1990), and the European Association for the Study of Diabetes (Claude Bernard Lecture, 1994). In addition to this recognition from the three leading professional societies in the field of diabetes, Dr. Reaven received the William S. Middleton Award for Outstanding Achievement in Medical Research from the Veterans Administration (1987), the Elliot Proctor Joslin Memorial Lecture (1990), the Nordisk-McGill Lecturer in Diabetes (1990), the Josiah Kirby Lilly Sr. Distinguished Service Award (1995), the Novartis Award for Longstanding Achievement in Diabetes (2000), the Sixth Linus Pauling Functional Medicine Award (2001), the Renold Medal of the American Diabetes Association (2002), and the Frontier in Science Award from the American Association of Clinical Endocrinologists (2003).

^top